EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 66 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71 | -51.0% | 238,034 | +15.5% | 0.00% | -100.0% |
Q2 2023 | $145 | -42.7% | 206,113 | -27.0% | 0.00% | 0.0% |
Q1 2023 | $253 | -56.2% | 282,471 | -42.4% | 0.00% | -66.7% |
Q4 2022 | $578 | -99.5% | 490,488 | +3575.4% | 0.00% | – |
Q2 2021 | $114,000 | +165.1% | 13,345 | +360.5% | 0.00% | – |
Q4 2019 | $43,000 | -65.0% | 2,898 | -75.0% | 0.00% | -100.0% |
Q2 2019 | $123,000 | -44.3% | 11,602 | -26.7% | 0.00% | 0.0% |
Q1 2019 | $221,000 | -58.7% | 15,838 | -69.9% | 0.00% | -66.7% |
Q4 2018 | $535,000 | -49.0% | 52,642 | -39.8% | 0.00% | -25.0% |
Q3 2018 | $1,049,000 | +52.7% | 87,427 | +55.4% | 0.00% | +33.3% |
Q2 2018 | $687,000 | +236.8% | 56,266 | +171.2% | 0.00% | +200.0% |
Q1 2018 | $204,000 | – | 20,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |